Characterizing and optimizing IgE and IgG4 microarray peptide assays for Ara h 2
表征和优化 Ara h 2 的 IgE 和 IgG4 微阵列肽测定
基本信息
- 批准号:10289505
- 负责人:
- 金额:$ 7.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-07 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:16 year oldAcuteAddressAffectAlbuminsAllergensAllergicAllergic ReactionAllergy to peanutsAmericanAnaphylaxisAngioneurotic EdemaAnxietyBindingBiological AssayBronchial SpasmCaregiversCessation of lifeChildClinicalClinical TrialsDataDiagnosticEnzyme-Linked Immunosorbent AssayEpitopesFaceFoodFood HypersensitivityHealthHealth Care CostsIgEIgG4ImmunoassayImmunoglobulinsInfantKnowledgeMeasurementMeasuresMediatingNorthern EuropeOutcome StudyPatientsPatternPeptidesPersonsPopulationPredictive ValuePrevalenceProcessProteinsPublic HealthQuality of lifeReactionReproducibilityRiskSamplingSeveritiesSwellingTestingUnited StatesUrticariabaseclinically relevantimprovedmast cellnegative affectoral immunotherapyscreeningtool
项目摘要
Project Summary:
Peanut allergy is recognized as one of the most severe food allergies due to its prevalence,
persistence, and the potential severity. Peanut allergy reactions vary from mild to severe, ranging
from acute hives, severe angioedema, swelling of the face, bronchospasm, anaphylaxis, to even
death. The US annual healthcare cost of managing peanut allergy is estimated to be several
billion dollars. Thus, there is an urgent need to develop improved diagnostics. Among the 17
known PN allergens, the highly homologous 2S albumins, Ara h 2 and Ara h 6, are the most
potent for eliciting IgE-mediated mast cell activation and measurement of specific IgE to either
Ara h 2 or Ara h 6 correlates best with clinically relevant PN allergy. Peptide microarrays have
been in use for a decade and are particularly useful for screening peptides and qualitative analysis
of immunoglobulin binding. We hypothesize that these peptide microarrays have the potential to
be more quantitative and become important diagnostics but there are important gaps in
knowledge in regards to the size of the peptides assayed, how samples are handled, sensitivity,
reproducibility and the dynamic range of the assays. We will use samples from a well
characterized clinical trial of oral immunotherapy to test the following hypotheses: 1) normalizing
sera based on PN-sIgE (or IgG4) or Ara h 2-sIgE (or IgG4) prior to assay will give more accurate
measure of quantitative binding to peptides that may be seen if sera are assayed at a fixed dilution
and 2) microarray assays are more sensitive than either Bt-ELISA or ImmunoCap®, but have a
more restricted dynamic range. The outcome of these studies will be an enhanced understanding
of the use of microarrays so that this important tool can be applied to a variety of allergic
conditions.
项目概要:
花生过敏被认为是最严重的食物过敏之一,因为它的流行,
持久性和潜在的严重性。花生过敏反应从轻微到严重不等,
从急性荨麻疹,严重的血管性水肿,面部肿胀,支气管痉挛,过敏反应,甚至
死亡据估计,美国每年用于治疗花生过敏的医疗费用为
亿美元因此,迫切需要开发改进的诊断方法。的17
已知的PN过敏原,高度同源的2S白蛋白,Ara h 2和Ara h 6,是最常见的
有效地引发IgE介导的肥大细胞活化,并测量特异性IgE
Ara h 2或Ara h 6与临床相关PN过敏相关性最好。肽微阵列具有
已经使用了十年,特别适用于筛选肽和定性分析
免疫球蛋白的结合。我们假设这些肽微阵列有潜力
更加量化并成为重要的诊断方法,但在
关于测定的肽的大小,如何处理样品,灵敏度,
测定的重现性和动态范围。我们将使用一口井里的样本
口服免疫疗法的特征性临床试验,以测试以下假设:1)正常化
在测定前基于PN-sIgE(或IgG 4)或Ara h 2-sIgE(或IgG 4)的血清将给出更准确的
如果在固定稀释度下测定血清,则可观察到的与肽的定量结合的量度
和2)微阵列测定比Bt-ELISA或ImmunoCap®更敏感,但具有
更严格的动态范围。这些研究的结果将是加深了解
微阵列的使用,使这一重要工具可以应用于各种过敏性
条件
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN C DRESKIN其他文献
STEPHEN C DRESKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN C DRESKIN', 18)}}的其他基金
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10685312 - 财政年份:2021
- 资助金额:
$ 7.78万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10490872 - 财政年份:2021
- 资助金额:
$ 7.78万 - 项目类别:
Characterizing and optimizing IgE and IgG4 microarray peptide assays for Ara h 2
表征和优化 Ara h 2 的 IgE 和 IgG4 微阵列肽测定
- 批准号:
10447170 - 财政年份:2021
- 资助金额:
$ 7.78万 - 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
- 批准号:
10345963 - 财政年份:2021
- 资助金额:
$ 7.78万 - 项目类别:
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
绘制 Ara h 2 和 Ara h 6 的关键表位
- 批准号:
8535604 - 财政年份:2012
- 资助金额:
$ 7.78万 - 项目类别:
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
绘制 Ara h 2 和 Ara h 6 的关键表位
- 批准号:
8271971 - 财政年份:2012
- 资助金额:
$ 7.78万 - 项目类别:
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
绘制 Ara h 2 和 Ara h 6 的关键表位
- 批准号:
8895251 - 财政年份:2012
- 资助金额:
$ 7.78万 - 项目类别:
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
绘制 Ara h 2 和 Ara h 6 的关键表位
- 批准号:
8699138 - 财政年份:2012
- 资助金额:
$ 7.78万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 7.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 7.78万 - 项目类别:
Operating Grants